Platelet CD62 expression and PDGF(AB) secretion in patients undergoing PTCA and treatment with abciximab

AIMS: To investigate a correlation of the platelet activation marker CD62 and secretion of the growth factor PDGF from platelets in coronary patients under therapy with the GPIIb/IIIa-inhibitor abciximab. METHODS: Flow cytometric assessment of fibrinogen binding (GPIIb/IIIa-binding site) and CD62 ex...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Graff, J, Andries, D, Elsner, M, Westrup, D, Bassus, S, Franz, N, Klinkhardt, U, Harder, S
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Science Inc 2001
Témata:
Pharmacodynamics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014496/
https://ncbi.nlm.nih.gov/pubmed/11422017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2001.01392.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky